Revance Therapeutics, Inc.
RVNC
Revenue
59.88M
▼-5.51M▼-8.43%
3 Months ChangeAssets
461.56M
▼-33.24M▼-6.72%
3 Months ChangeLiabilities
624.59M
▲57.00k▲0.009127%
3 Months ChangeFree Cash Flow
-67.65M
▲2.72M▲3.86%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-11-01
Form 8-K
ID: 0001140361-24-044892
2024-10-28
Form 8-K
ID: 0001140361-24-044317
2024-10-18
Form 8-K
ID: 0001140361-24-043670
2024-10-04
Form 8-K
ID: 0001140361-24-042816
2024-09-23
Form 8-K
ID: 0001140361-24-041600
2024-09-09
Form 8-K
ID: 0001479290-24-000120
2024-08-28
Form 8-K
ID: 0001479290-24-000118
2024-08-12
Form 8-K
ID: 0001193125-24-198448
2024-08-09
Form 8-K
ID: 0001479290-24-000114
2024-08-08
Form 10-Q
ID: 0001479290-24-000111